Claudia R Libertin
Overview
Explore the profile of Claudia R Libertin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sise M, Santos J, Goldman J, Tuttle K, Teixeira J, Seibert A, et al.
Clin Infect Dis
. 2024 Jun;
79(5):1172-1181.
PMID: 38913574
Background: Few antiviral therapies have been studied in patients with coronavirus disease 2019 (COVID-19) and kidney impairment. Herein, the efficacy, safety, and pharmacokinetics of remdesivir, its metabolites, and sulfobutylether-β-cyclodextrin excipient...
2.
Kempaiah P, Libertin C, Chitale R, Naeyma I, Pleqi V, Sheele J, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672225
Background: While 'immuno-competence' is a well-known term, it lacks an operational definition. To address this omission, this study explored whether the temporal and structured data of the complete blood cell...
3.
Satashia P, Moreno Franco P, Rivas A, Isha S, Hanson A, Narra S, et al.
Front Med (Lausanne)
. 2023 Nov;
10:1240426.
PMID: 38020180
Background: The COVID-19 pandemic intensified the use of scarce resources, including extracorporeal membrane oxygenation (ECMO) and mechanical ventilation (MV). The combinatorial features of the immune system may be considered to...
4.
Isha S, Satashia P, Yarrarapu S, Govero A, Harrison M, Baig H, et al.
Front Med (Lausanne)
. 2023 Apr;
10:1071741.
PMID: 37089586
Background: The Surviving Sepsis Campaign suggested preferential resuscitation with balanced crystalloids, such as Lactated Ringer's (LR), although the level of recommendation was weak, and the quality of evidence was low....
5.
Squire J, Libertin C, Powers H, Nelson J, Brumble L, Laham F, et al.
Int J Infect Dis
. 2023 Apr;
131:162-165.
PMID: 37037391
Tumor necrosis factor-a inhibitors can be associated with increased risk of infections, particularly reactivation of latent tuberculosis or nontuberculous mycobacterium (NTM). However, because disseminated NTM is rare, inborn errors of...
6.
Libertin C, Kempaiah P, Gupta Y, Fair J, van Regenmortel M, Antoniades A, et al.
Mol Aspects Med
. 2022 Sep;
91:101142.
PMID: 36116999
Topics expected to influence personalized medicine (PM), where medical decisions, practices, and treatments are tailored to the individual patient, are reviewed. Lack of discrimination due to different biological conditions that...
7.
Bhakta S, Sanghavi D, Johnson P, Kunze K, Neville M, Wadei H, et al.
Int J Infect Dis
. 2022 Apr;
120:88-95.
PMID: 35487339
Objectives: The emergence of SARS-CoV-2 variants of concern has led to significant phenotypical changes in transmissibility, virulence, and public health measures. Our study used clinical data to compare characteristics between...
8.
Verma J, Libertin C, Gupta Y, Khanna G, Kumar R, Arora B, et al.
Front Immunol
. 2022 Mar;
13:794006.
PMID: 35281033
To rapidly prognosticate and generate hypotheses on pathogenesis, leukocyte multi-cellularity was evaluated in SARS-CoV-2 infected patients treated in India or the United States (152 individuals, 384 temporal observations). Within hospital...
9.
Low antispike antibody levels correlate with poor outcomes in COVID-19 breakthrough hospitalizations
Sanghavi D, Bhakta S, Wadei H, Bosch W, Cowart J, Carter R, et al.
J Intern Med
. 2022 Feb;
292(1):127-135.
PMID: 35194861
Background: While COVID-19 immunization programs attempted to reach targeted rates, cases rose significantly since the emergence of the delta variant. This retrospective cohort study describes the correlation between antispike antibodies...
10.
Sheele J, Libertin C, Fink I, Jensen T, Dasalla N, Lyon T
J Emerg Med
. 2022 Jan;
62(3):368-377.
PMID: 35000812
Background: The Proteeae group (i.e., Proteus species, Morganella morganii, and Providencia species) frequently causes urinary tract infections (UTIs) and is generally resistant to nitrofurantoin. Proteeae species can produce urease, which...